-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Amicus Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q2 2018 to Q3 2024.
- Amicus Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $2.17M, a 2.6% decline year-over-year.
- Amicus Therapeutics, Inc. Depreciation, Depletion and Amortization for the twelve months ending September 30, 2024 was $8.69M, a 24.1% increase year-over-year.
- Amicus Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $7.87M, a 47.4% increase from 2022.
- Amicus Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $5.34M, a 14% decline from 2021.
- Amicus Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $6.21M, a 29.8% decline from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)